Literature DB >> 33454021

Genetic diseases of the Kennedy pathways for membrane synthesis.

Mahtab Tavasoli1, Sarah Lahire2, Taryn Reid1, Maren Brodovsky1, Christopher R McMaster3.   

Abstract

The two branches of the Kennedy pathways (CDP-choline and CDP-ethanolamine) are the predominant pathways responsible for the synthesis of the most abundant phospholipids, phosphatidylcholine and phosphatidylethanolamine, respectively, in mammalian membranes. Recently, hereditary diseases associated with single gene mutations in the Kennedy pathways have been identified. Interestingly, genetic diseases within the same pathway vary greatly, ranging from muscular dystrophy to spastic paraplegia to a childhood blinding disorder to bone deformations. Indeed, different point mutations in the same gene (PCYT1; CCTα) result in at least three distinct diseases. In this review, we will summarize and review the genetic diseases associated with mutations in genes of the Kennedy pathway for phospholipid synthesis. These single-gene disorders provide insight, indeed direct genotype-phenotype relationships, into the biological functions of specific enzymes of the Kennedy pathway. We discuss potential mechanisms of how mutations within the same pathway can cause disparate disease.
Copyright © 2020 © 2020 Tavasoli et al. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  genetic disease; inherited; lipid; membrane; metabolism; phosphatidylcholine; phosphatidylethanolamine; phospholipid

Mesh:

Substances:

Year:  2020        PMID: 33454021      PMCID: PMC7762932          DOI: 10.1074/jbc.REV120.013529

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis.

Authors:  Roger B Sher; Chieko Aoyama; Kimberly A Huebsch; Shaonin Ji; Janos Kerner; Yan Yang; Wayne N Frankel; Charles L Hoppel; Philip A Wood; Dennis E Vance; Gregory A Cox
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

2.  Disease-linked mutations in the phosphatidylcholine regulatory enzyme CCTα impair enzymatic activity and fold stability.

Authors:  Rosemary B Cornell; Svetla G Taneva; Melissa K Dennis; Ronnie Tse; Randeep K Dhillon; Jaeyong Lee
Journal:  J Biol Chem       Date:  2018-12-17       Impact factor: 5.157

3.  Mutations in PCYT1A cause spondylometaphyseal dysplasia with cone-rod dystrophy.

Authors:  Guilherme L Yamamoto; Wagner A R Baratela; Tatiana F Almeida; Monize Lazar; Clara L Afonso; Maria K Oyamada; Lisa Suzuki; Luiz A N Oliveira; Ester S Ramos; Chong A Kim; Maria Rita Passos-Bueno; Débora R Bertola
Journal:  Am J Hum Genet       Date:  2014-01-02       Impact factor: 11.025

Review 4.  Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.

Authors:  Karen D Corbin; Steven H Zeisel
Journal:  Curr Opin Gastroenterol       Date:  2012-03       Impact factor: 3.287

5.  Cloning, genomic organization, and characterization of a human cholinephosphotransferase.

Authors:  A L Henneberry; G Wistow; C R McMaster
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

6.  The intrinsically disordered nuclear localization signal and phosphorylation segments distinguish the membrane affinity of two cytidylyltransferase isoforms.

Authors:  Melissa K Dennis; Svetla G Taneva; Rosemary B Cornell
Journal:  J Biol Chem       Date:  2011-02-08       Impact factor: 5.157

7.  Chemical cross-linking reveals a dimeric structure for CTP:phosphocholine cytidylyltransferase.

Authors:  R Cornell
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

8.  Identification of the nuclear localization signal of rat liver CTP:phosphocholine cytidylyltransferase.

Authors:  Y Wang; J I MacDonald; C Kent
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

Review 9.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

Review 10.  The ins and outs of endoplasmic reticulum-controlled lipid biosynthesis.

Authors:  Julie Jacquemyn; Ana Cascalho; Rose E Goodchild
Journal:  EMBO Rep       Date:  2017-10-26       Impact factor: 8.807

View more
  5 in total

1.  Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease.

Authors:  Yan-Ni Wang; Zhi-Hao Zhang; Hong-Jiao Liu; Zhi-Yuan Guo; Liang Zou; Ya-Mei Zhang; Ying-Yong Zhao
Journal:  Acta Pharmacol Sin       Date:  2022-08-03       Impact factor: 7.169

Review 2.  Signaling pathways of chronic kidney diseases, implications for therapeutics.

Authors:  Qian Yuan; Ben Tang; Chun Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

3.  BUMPY STEM Is an Arabidopsis Choline/Ethanolamine Kinase Required for Normal Development and Chilling Responses.

Authors:  Christina Rabeler; Mingjie Chen; Nick Kaplinsky
Journal:  Front Plant Sci       Date:  2022-04-29       Impact factor: 6.627

4.  A mathematical model of GLUT1 modulation in rods and RPE and its differential impact in cell metabolism.

Authors:  Andrea Aparicio; Erika T Camacho; Nancy J Philp; Stephen A Wirkus
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

Review 5.  Megaconial congenital muscular dystrophy due to novel CHKB variants: a case report and literature review.

Authors:  Francesca Magri; Sara Antognozzi; Michela Ripolone; Simona Zanotti; Laura Napoli; Patrizia Ciscato; Daniele Velardo; Giulietta Scuvera; Valeria Nicotra; Antonella Giacobbe; Donatella Milani; Francesco Fortunato; Manuela Garbellini; Monica Sciacco; Stefania Corti; Giacomo Pietro Comi; Dario Ronchi
Journal:  Skelet Muscle       Date:  2022-09-29       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.